Overview

Study Evaluating TotelleĀ® in Menopausal Symptoms and Sexual Function

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the tolerability, bleeding patterns and acceptability of TotelleĀ® 1mg administered to a population of Brazilian women in a continuous combined regime for hormone replacement therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer